6-(Trifluoromethoxy)-1H-indole-3-carbaldehyde

Catalog No.: 
ACTZWK028
CAS No.: 
467451-62-3
Molecular Formula: 
C10H6F3NO2
Molecular Weight: 
229.16
6-(Trifluoromethoxy)-1H-indole-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$180.00InquiryInquiry
250mg98%$285.00InquiryInquiry
1g98%$715.00InquiryInquiry
5g98%$2151.00InquiryInquiry
10g98%$3585.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Trifluoromethoxy)-1H-indole-3-carbaldehyde
IUPAC Name6-(trifluoromethoxy)-1H-indole-3-carbaldehyde
MDL No.MFCD09954783
Molecular FormulaC10H6F3NO2
Molecular Weight229.16
SMILESO=CC1=CNC2=C1C=CC(OC(F)(F)F)=C2
InChI KeySYHWDFUXSQIWHE-UHFFFAOYSA-N
Synonym6-(Trifluoromethoxy)-1H-indole-3-carbaldehyde;1H-Indole-3-carboxaldehyde, 6-(trifluoromethoxy)-
CAS No.467451-62-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTZWK028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVIGA436 route compound structure diagram
    ACVIGA436467451-91-8In Stock
  4. Then
  5. ACTZWK028 route product structure diagram
    ACTZWK028467451-62-3
Inquiry

2. ACTZWK028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTZWK028 route product structure diagram
    ACTZWK028467451-62-3
Inquiry

3. ACTZWK028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZWK028 route product structure diagram
    ACTZWK028467451-62-3
Inquiry

Comments (0)